Clinical Trial Update: Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide and procarbazine in recurrent or progressive malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors

Drugs mentioned

• Procarbazine (procarbazine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED